Privium Fund Management B.V.
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Schedule 13D/13G stakes
Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.
| Company | Schedule | Event date | Filed | Shares | % of class | Status |
|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics N.V. | 13G/A | Jul 15, 2026 | 4mo | 5,528,862 | 5.2% | Current |
A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, the newest measured quarter, never from the firm's own description.
Closest benchmark: the Nasdaq-100 as of 2026-06-30, active share 83.1%; sector active share 40.7% against the combined 13F book's sector weights.
Over time 19 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
58 tracked positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
As of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 30.8% | $158,788,550 |
| Healthcare | 25.2% | $130,103,174 |
| Consumer Cyclical | 22.4% | $115,388,792 |
| Industrials | 7.3% | $37,715,000 |
| Financial Services | 5.4% | $27,814,429 |
| Communication Services | 4.9% | $25,518,740 |
| Real Estate | 2.4% | $12,183,942 |
| Consumer Defensive | 0.6% | $2,889,991 |
| Energy | 0.5% | $2,753,500 |
| Basic Materials | 0.3% | $1,787,570 |
| Unclassified | 0.1% | $591,117 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OPEN | Opendoor Technologies Inc. | +1,200,000 | 5,140,904 | $12,183,942 | |
| SPCX | Space Exploration Technologies Corp | +210,000 | 250,000 | $37,715,000 | |
| ABEV | Ambev S.A. | +187,556 | 989,723 | $2,889,991 | |
| AUTL | Autolus Therapeutics plc | +106,060 | 469,490 | $910,810 | |
| BTG | B2gold Corp | +70,422 | 265,505 | $1,385,936 | |
| CBRS | Cerebras Systems Inc. | +50,500 | 111,000 | $19,719,150 | |
| TSHA | Taysha Gene Therapies, Inc. | +34,000 | 232,900 | $1,134,223 | |
| SRPT | Sarepta Therapeutics, Inc. | +30,105 | 166,605 | $3,035,543 | |
| IREN | IREN Ltd | +30,000 | 370,150 | $15,131,732 | |
| IONS | Ionis Pharmaceuticals Inc | +29,079 | 349,003 | $15,582,983 | |
| BEAM | Beam Therapeutics Inc. | +21,000 | 91,282 | $2,231,844 | |
| MGTX | MeiraGTx Holdings plc | +12,400 | 208,512 | $2,293,632 | |
| RIG | Transocean Ltd. | +10,095 | 155,699 | $815,862 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | +9,235 | 20,607 | $5,084,571 | |
| ZTS | Zoetis Inc. | +6,321 | 23,643 | $1,650,990 | |
| CRSP | CRISPR Therapeutics AG | +4,000 | 48,974 | $2,709,241 | |
| RNAC | Cartesian Therapeutics, Inc. | +3,325 | 155,000 | $1,117,550 | |
| AXSM | Axsome Therapeutics, Inc. | +3,000 | 42,944 | $7,918,444 | |
| BNTX | BioNTech SE | +2,000 | 32,100 | $3,155,430 | |
| LULU | lululemon athletica inc. | +1,960 | 7,023 | $675,542 | |
| MOH | Molina Healthcare, Inc. | +1,085 | 4,064 | $768,502 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| QURE | uniQure N.V. | −112,125 | 216,197 | $5,223,319 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −105,763 | 233,037 | $3,502,546 | |
| URGN | UroGen Pharma Ltd. | −102,085 | 107,915 | $4,384,586 | |
| ARQT | Arcutis Biotherapeutics, Inc. | −66,174 | 333,193 | $8,806,290 | |
| SHOP | Shopify Inc. | −65,000 | 305,000 | $45,231,500 | |
| PRQR | ProQR Therapeutics N.V. | −52,875 | 5,467,149 | $9,075,467 | |
| SPOT | Spotify Technology S.A. | −22,000 | 33,000 | $16,083,540 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −18,404 | 215,818 | $14,125,288 | |
| NOV | NOV Inc. | −7,976 | 34,050 | $637,756 | |
| NU | Nu Holdings Ltd. | −5,832 | 38,168 | $483,206 | |
| TSLA | Tesla, Inc. | −3,000 | 225,000 | $79,832,250 | |
| SA | Seabridge Gold Inc | −2,340 | 14,172 | $401,634 | |
| KRYS | Krystal Biotech, Inc. | −1,200 | 9,970 | $3,315,623 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NBIS | Nebius Group N.V. | 40,000 | $9,435,200 | |
| BBIO | BridgeBio Pharma, Inc. | 89,151 | $5,866,135 | |
| NBIX | Neurocrine Biosciences Inc | 26,200 | $3,716,208 | |
| URNM | 8,178 | $388,127 | ||
| RRC | Range Resources Corp | 7,147 | $264,724 | |
| EXE | EXPAND ENERGY Corp | 3,046 | $256,138 | |
| EQT | EQT Corp | 5,266 | $255,716 | |
| PFE | Pfizer Inc | 7,406 | $211,219 | |
| COPY | Tweedy, Browne Insider + Value ETF | 13,250 | $202,990 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ASTS | AST SpaceMobile, Inc. | 145,000 | $12,884,700 | |
| VRTX | Vertex Pharmaceuticals Inc | 9,400 | $4,669,262 | |
| VRDN | Viridian Therapeutics, Inc.\DE | 173,516 | $3,187,488 | |
| HIMS | Hims & Hers Health, Inc. | 80,000 | $2,773,600 | |
| ZLAB | Zai Lab Ltd | 122,189 | $2,321,591 | |
| MRNA | Moderna, Inc. | 29,994 | $2,100,479 | |
| MICC | Magnum Ice Cream Co N.V. | 98,221 | $1,710,027 | |
| WVE | Wave Life Sciences, Inc. | 241,010 | $1,400,268 | |
| LEGN | Legend Biotech Corp | 35,400 | $1,022,352 | |
| TTE | TotalEnergies SE | 10,723 | $833,820 | |
| TDW | Tidewater Inc | 8,683 | $578,548 | |
| CSANY | Cosan S.A. | 52,000 | $149,760 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
Reduced | 225,000 | $79,832,250 | 15.49% | |
| SHOP |
Shopify Inc.
Technology
|
Reduced | 305,000 | $45,231,500 | 8.77% | |
| AMD |
Advanced Micro Devices Inc
Technology
|
Held | 62,000 | $37,929,120 | 7.36% | |
| SPCX |
Space Exploration Technologies Corp
Industrials
|
Added | 250,000 | $37,715,000 | 7.32% | |
| PLTR |
Palantir Technologies Inc.
Technology
|
Held | 200,000 | $37,410,000 | 7.26% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Held | 140,000 | $34,881,000 | 6.77% | |
| CBRS |
Cerebras Systems Inc.
Technology
|
Added | 111,000 | $19,719,150 | 3.82% | |
| NVDA |
Nvidia Corp
Technology
|
Held | 81,000 | $18,498,780 | 3.59% | |
| SPOT |
Spotify Technology S.A.
Communication Services
|
Reduced | 33,000 | $16,083,540 | 3.12% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 349,003 | $15,582,983 | 3.02% | |
| IREN |
IREN Ltd
Financial Services
|
Added | 370,150 | $15,131,732 | 2.94% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 215,818 | $14,125,288 | 2.74% | |
| LMND |
Lemonade, Inc.
Financial Services
|
Held | 270,259 | $12,199,491 | 2.37% | |
| OPEN |
Opendoor Technologies Inc.
Real Estate
|
Added | 5,140,904 | $12,183,942 | 2.36% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 48,400 | $10,932,592 | 2.12% | |
| NBIS |
Nebius Group N.V.
Communication Services
|
NEW | 40,000 | $9,435,200 | 1.83% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Reduced | 5,467,149 | $9,075,467 | 1.76% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Reduced | 333,193 | $8,806,290 | 1.71% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 42,944 | $7,918,444 | 1.54% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 89,151 | $5,866,135 | 1.14% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 216,197 | $5,223,319 | 1.01% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 20,607 | $5,084,571 | 0.99% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Held | 229,857 | $4,751,144 | 0.92% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Held | 75,000 | $4,500,000 | 0.87% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Reduced | 107,915 | $4,384,586 | 0.85% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
NEW | 26,200 | $3,716,208 | 0.72% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 233,037 | $3,502,546 | 0.68% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 9,970 | $3,315,623 | 0.64% | |
| BNTX |
BioNTech SE
Healthcare
|
Added | 32,100 | $3,155,430 | 0.61% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 166,605 | $3,035,543 | 0.59% | |
| ABEV |
Ambev S.A.
Consumer Defensive
|
Added | 989,723 | $2,889,991 | 0.56% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Added | 48,974 | $2,709,241 | 0.53% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Added | 208,512 | $2,293,632 | 0.44% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 91,282 | $2,231,844 | 0.43% | |
| ZTS |
Zoetis Inc.
Healthcare
|
Added | 23,643 | $1,650,990 | 0.32% | |
| BTG |
B2gold Corp
Basic Materials
|
Added | 265,505 | $1,385,936 | 0.27% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Held | 90,110 | $1,289,474 | 0.25% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 232,900 | $1,134,223 | 0.22% | |
| RNAC |
Cartesian Therapeutics, Inc.
Healthcare
|
Added | 155,000 | $1,117,550 | 0.22% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 414,311 | $981,917 | 0.19% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Added | 469,490 | $910,810 | 0.18% | |
| RIG |
Transocean Ltd.
Energy
|
Added | 155,699 | $815,862 | 0.16% | |
| MOH |
Molina Healthcare, Inc.
Healthcare
|
Added | 4,064 | $768,502 | 0.15% | |
| LULU |
lululemon athletica inc.
Consumer Cyclical
|
Added | 7,023 | $675,542 | 0.13% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 244,146 | $642,103 | 0.12% | |
| NOV |
NOV Inc.
Energy
|
Reduced | 34,050 | $637,756 | 0.12% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Held | 155,000 | $523,900 | 0.10% | |
| SD |
Sandridge Energy Inc
Energy
|
Held | 38,792 | $523,304 | 0.10% | |
| NU |
Nu Holdings Ltd.
Financial Services
|
Reduced | 38,168 | $483,206 | 0.09% | |
| SA |
Seabridge Gold Inc
Basic Materials
|
Reduced | 14,172 | $401,634 | 0.08% |
Showing the top 50 of 58 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.